Side-by-side comparison of AI visibility scores, market position, and capabilities
Oracle Corporation's healthcare IT division (rebranded Cerner, $28.3B acquisition 2022); #2 US hospital EHR, VA/DoD federal EHR program, OCI cloud migration + ambient clinical AI competing with Epic Systems.
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, revenue cycle management, and population health analytics to hospitals, health systems, physician practices, ambulatory clinics, and government health agencies globally — operating as the rebranded Cerner Corporation following Oracle's $28.3 billion acquisition of Cerner in June 2022, the largest acquisition in Oracle's history. Oracle Health's EHR platform (the Cerner Millennium clinical information system) powers clinical documentation, physician order entry, nursing workflows, medication administration, and patient care coordination for approximately 30% of US hospitals — making Oracle Health the second-largest EHR vendor in the US hospital market after Epic Systems. A major integration program is underway to migrate Cerner's clinical applications to Oracle Cloud Infrastructure (OCI), enabling Oracle Health to leverage Oracle's cloud scale, Oracle's AI capabilities (generative AI for clinical documentation, ambient listening for physician notes), and Oracle's database performance advantages for health record analytics. Oracle Corporation named Clay Magouyrk and Mike Sicilia as co-CEOs in 2025 (replacing Safra Catz), positioning Oracle Health's clinical platform to benefit from the next-generation Oracle leadership team's emphasis on cloud and AI transformation.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.